Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Translational Medicine
Published in: Journal of Translational Medicine 1/2009

Open Access 01-12-2009 | Review

Surgical inflammation: a pathophysiological rainbow

Authors: Jose-Ignacio Arias, María-Angeles Aller, Jaime Arias

Published in: Journal of Translational Medicine | Issue 1/2009

Login to get access

Abstract

Tetrapyrrole molecules are distributed in virtually all living organisms on Earth. In mammals, tetrapyrrole end products are closely linked to oxygen metabolism. Since increasingly complex trophic functional systems for using oxygen are considered in the post-traumatic inflammatory response, it can be suggested that tetrapyrrole molecules and, particularly their derived pigments, play a key role in modulating inflammation.
In this way, the diverse colorfulness that the inflammatory response triggers during its evolution would reflect the major pathophysiological importance of these pigments in each one of its phases. Therefore, the need of exploiting this color resource could be considered for both the diagnosis and treatment of the inflammation.
Appendix
Available only for authorised users
Literature
1.
Kohl BA, Deutschman CS: The inflammatory response to surgery and trauma. Curr Opin Crit Care. 2006, 12: 325-332.PubMed
2.
Aller MA, Arias JL, Nava MP, Arias J: Post-traumatic inflammation is a complex response based on the pathological expression of the nervous, immune and endocrine functional systems. Exp Biol Med. 2004, 229: 170-181.
3.
Punchard NA, Whelan CJ, Adcock I: The journal of inflammation. J Inflamm (Lond). 2004, 1: 1-
4.
Aller MA, Arias JL, Sanchez-Patan F, Arias J: The inflammatory response: An efficient way of life. Med Sci Monit. 2006, 12: RA225-234.PubMed
5.
6.
Arias J, Aller MA, Arias JI, Lorente L: Traumatismos mecánicos: Contusión. Herida. Fractura. Fisiopatología Quirúrgica. Edited by: Arias J, Aller MA, Arias JI, Lorente L. 1999, Madrid: Ed. Tébar, Chapter 2: 35-49.
7.
Velde Vande C, Cizeau J, Dubik D, Alimonti J, Brown T, Israels S, Hakem R, Greenberg AH: BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol. 2000, 20: 5454-5468.
8.
Jin Z, El-Deiry WS: Overview of cell death signaling pathways. Cancer Biol & Ther. 2005, 4: 139-163.
9.
Rosser BG, Gores GJ: Liver cell necrosis: Cellular mechanisms and clinical implications. Gastroenterology. 1995, 108: 252-275.PubMed
10.
Aller MA, Arias JL, Nava MP, Arias J: Evolutive trophic phases of the systemic acute inflammatory response, oxygen use mechanisms and metamorphosis. Psicothema. 2004, 16: 369-372.
11.
Aller MA, Arias JL, Arias J: The mast cell integrates the splanchnic and systemic inflammatory response in portal hypertension. J Transl Med. 2007, 5: 44-PubMedCentralPubMed
12.
Yang JG, Rowe DJ, Dzwierzynski W, Yan YH, Zhang LL, Sanger J, Matloub HS: Pathophysiological process of traumatic vascular spasm in multiple crush injury. J Reconstr Microsurg. 2007, 23: 237-242.
13.
Chien LC, Lu KJ, Wo CC, Shoemaker WC: Hemodynamic patterns preceding circulatory deterioration and death after trauma. J Trauma. 2007, 62: 928-932.PubMed
14.
Garrison RN, Zakaria ER: Peritoneal resuscitation. Am J Surg. 2005, 190: 181-185.PubMed
15.
Alanezi K, Alanzi F, Faidi S, Sprague S, Cadeddu M, Baillie F, Bowser D, McCallum A, Bhandari M: Survival rates for adult trauma patients who require cardiopulmonary resuscitation. CJEM. 2004, 6 (4): 263-265.PubMed
16.
Willis CD, Cameron PA, Bernard SA, Fitzgerald M: Cardiopulmonary resuscitation after traumatic cardiac arrest is not always futile. Injury. 2006, 37: 448-454.PubMed
17.
SOS-KANTO study group: Cardiopulmonary resuscitation by bysbystanders with chest compression only (SOS-KANTO): an observational study. Lancet. 2007, 369: 920-926.
18.
Hopson LR, Hirsh E, Delgado J, Domeier RM, McSwain NE, Krohmer J: Guidelines for withholding or termination of resuscitation in prehospital traumatic cardiopulmonary arrest: joint position statement of the national association of EMS physicians and the american college of surgeons committee on trauma. J Am Coll Surg. 2003, 196: 106-112.PubMed
19.
Gentilello LM, Pierson DJ: Trauma critical care. Am J Respir Crit Care Med. 2001, 163: 604-607.PubMed
20.
Moore FA, McKinley BA, Moore EE: The next generation in shock resuscitation. Lancet. 2004, 363: 1988-1996.PubMed
21.
Ho AMH, Karmakar MK, Dion PW: Are we giving enough coagulation factors during major trauma resuscitation?. Am J Surg. 2005, 190: 479-484.PubMed
22.
Weisfeldt ML, Becker LB: Resuscitation after cardiac arrest: A 3-phase time-sensitive model. JAMA. 2002, 288: 3035-3038.PubMed
23.
Ali BA, Zafari AM: Cardiopulmonary resuscitation and emergency cardiovascular care: Review of the current guidelines. Ann Intern Med. 2007, 147: 171-179.PubMed
24.
Pace MC, Mazzariello L, Passavanti MB, Sansone P, Barbarisi M, Aurillo C: Neurobiology of pain. J Cell Physiol. 2006, 209: 8-12.PubMed
25.
26.
McMahon SB, Cafferty WBJ, Marchand F: Immune and glial cell factors as pain mediators and modulators. Exp Neurol. 2005, 192: 444-462.PubMed
27.
Rittner HL, Brack A: Chemokines and pain. Curr Opin Investig Drugs. 2006, 7: 643-646.PubMed
28.
Pezet S, McMahon SB: Neurotrophins: Mediators and modulators of pain. Ann Rev Neurosci. 2006, 29: 507-538.PubMed
29.
McEwen BS: Physiology and neurobiology of stress and adaptation: Central role of the brain. Physiol Rev. 2007, 87: 873-904.PubMed
30.
Clarke RW, Harris J: The organization of motor responses to noxious stimuli. Brain Res Rev. 2004, 46: 163-172.PubMed
31.
Schmidt R, McDonagh AF: The enzymatic formation of bilirubin. Ann NY Acad Sci. 1975, 244: 533-552.
32.
Maines MD, Cohn J: Bile pigment formation by skin heme oxygenase: Studies on the response of the enzyme to heme compounds and tissue injury. J Exp Med. 1977, 145: 1054-1059.PubMed
33.
Furuyama K, Kaneko K, Vargas PD: Heme as a magnificient molecule with multiple missions: Heme determines its own fate and governs cellular homeostasis. Tohoku J Exp Med. 2007, 213: 1-16.PubMed
34.
Otterbein LE, Soares MP, Yamashita K, Bach FH: Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 2003, 24: 449-455.PubMed
35.
Tang LM, Wang YP, Wang K, Pu LY, Zhang F, Li XC, Kong LB, Sun BC, Li GQ, Wang XH: Exogenous biliverdin ameoliorates ischemia-reperfusion injury in small-for-size rat liver grafts. Transplant Proc. 2007, 39: 1338-1344.PubMed
36.
Freitas A, Alves-Filho JC, Secco DD, Neto AF, Ferrerira SH, Barja-Fidalgo C, Cunha FQ: Heme oxygenase/carbon monoxide-biliverdin pathway down regulates neutrophil rolling, adhesion and migration in acute inflammation. Br J Pharmacol. 2006, 149: 345-354.PubMedCentralPubMed
37.
Seta F, Bellner L, Rezzani R, Regan RF, Dunn MW, Abraham NG, Gronert K, Laniado-Schwartzman M: Heme oxygenase-2 is a critical determinant for execution of an acute inflammatory and reparative response. Am J Pathol. 2006, 169: 1612-1623.PubMedCentralPubMed
38.
McCoubrey WKJr, Huang TJ, Maines MD: Isolation and characterization of a cDNA from the rat brain that encodes hemeprotein heme oxygenase-3. Eur J Biochem. 1997, 247: 725-732.PubMed
39.
Ding Y, Zhang Y-Z, Furuyama K, Ogawa K, Igarashi K, Shibahara S: Down-regulation of heme oxygenase-2 is associated with the increased expression of heme oxygenase-1 in human cell lines. FEBS J. 2006, 273: 5333-5346.PubMed
40.
Orlinsky M, Shoemaker W, Reis ED, Kerstein MD: Current controversies in shock and resuscitation. Surg Clin North Am. 2001, 81: 1217-1262.PubMed
41.
Keel M, Trentz O: Pathophysiology of polytrauma. Injury. 2005, 36: 691-709.PubMed
42.
Martin L, Khalil H: How much reduced hemoglobin is necessary to generate central cyanosis?. Chest. 1990, 97: 182-185.PubMed
43.
Lundsgaard C, Van Sylke DD: The Quantitative Influences of Certain Factors Involved in the Production of Cyanosis. Proc Natl Acad Sci USA. 1922, 8: 280-282.PubMedCentralPubMed
44.
Maines MD: Biliverdin reductase: PKC interaction at the cross-talk of MAPK and PI3K signaling pathways. Antioxid Redox Signal. 2007, 9: 1-9.
45.
Kohchi T, Mukougawa K, Frankenberg N, Masuda M, Yokota A, Lagarias JC: The arabidopsis HYE gene encodes phytochromobilin synthase, a ferredoxin-dependent biliverdin reductase. Plant Cell. 2001, 13: 425-436.PubMedCentralPubMed
46.
Pachori AS, Smith A, McDonald P, Zhang L, Dzau VJ, Melo LG: Heme-oxygenase-1 induced protection against hypoxia/reoxygenation is dependent on biliverdin reductase and its interaction with Pi3k/AKT pathway. J Mol Cell Cardiol. 2007, 43: 580-592.PubMedCentralPubMed
47.
Vitek L, Schwertner HA: The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. Adv Clin Chem. 2007, 43: 1-57.PubMed
48.
Ollinger R, Wang H, Yamashita K, Wegiel B, Thomas M, Margreiter R, Bach FH: Therapeutic applications of bilirubin and biliverdin in transplantation. Antioxid Redox Signal. 2007, 9: 2175-2185.PubMed
49.
Bulmer AC, Ried K, Blanchfield JT, Wagner KH: The anti-mutagenic properties of bile pigments. Mutat Res. 2008, 658: 28-41.PubMed
50.
51.
Monaco JL, Lawrence WT: Acute wound healing. An overview. Clin Plastic Surg. 2003, 30: 1-12.
52.
Sherwood ER, Toliver-Kinsky T: Mechanisms of inflammatory response. Dest Pract Res Clin Anesth. 2004, 18: 385-405.
53.
Liu GY, Essex A, Buchanan JT, Datta V, Hoffman HM, Bastia NJF, Fierer J, Nizet V: Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J Exp Med. 2005, 202 (2): 209-215.PubMedCentralPubMed
54.
Deitch EA: Infection in the compromised host. Surgical Infections. Surg Clin North Am. Edited by: Howard RJ. 1988, 68: 181-197.
55.
Ohkusu K: Cost-effective and rapid presumptive identification of gram-negative bacilli in routine urine, pus and stool cultures: evaluation of the use of CHRO Magar orientation medium in conjuntion with simple biochemical tests. J Clin Microbiol. 2000, 38: 4586-4592.PubMedCentralPubMed
56.
Hau T, Haaga JR, Aeder MI: Pathophysiooogy, diagnosis and treatment of abdominal abscesses. Curr Probl Surg. 1984, 21: 1-82.PubMed
57.
Iwatsuki K, Yamasaki O, Morizane S, Oono T: Staphylococcus cutaneous infections: Invasión, evasión and aggresion. J Dermatol Sci. 2006, 42: 203-214.PubMed
58.
Loo WTY, Sasano H, Chow LWC: Pro-inflammatory cytokine, matrix metalloproteinases and TIMP-1 are involved in wound healing after mastectomy in invasive breast cancer patients. Biomed Pharmacother. 2007, 61: 548-552.PubMed
59.
Nerusu KC, Warner RL, Bhagavathula N, McClintock SD, Johnson KJ, Varani J: Matrix metalloproteinase-3 (stromelysin-1) in acute inflammatory tissue injury. Exp Mol Pathol. 2007, 83: 169-176.PubMedCentralPubMed
60.
Gruys E, Toussaint MJM, Niewold TA, Koopmans SJ: Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci. 2005, 6B: 1045-1056.
61.
Qin X: Inactivation of digestive proteases by deconjugated bilirubin: the possible evolutionary driving force for bilirubin or biliverdin predominance in animals. Gut. 2007, 56: 1641-1642.PubMedCentralPubMed
62.
Qin XF: Impaired inactivation of digestive proteases by deconjugated bilirubin: the possible mechanism for inflammatory bowel disease. Med Hypotheses. 2002, 59: 159-163.PubMed
63.
Ascenzi P, Bocedi A, Visca P, Altruda F, Tolosano E, Beringhelli T, Fasano M: Hemoglobin and heme scavenging. IUBMB Life. 2005, 57: 749-759.PubMed
64.
Reniere ML, Torres VJ, Skaar EP: Intracellular metalloporphyrin metabolism in staphylococcus aureus. Biometals. 2007, 20: 333-345.PubMed
65.
Mastoraki A, Karatzis E, Mastoraki S, Kriaras I, Sfirakis P, Geroulands S: Postoperative jaundice after cardiac surgery. Hepatobiliary Pancreat Dis Int. 2007, 6: 383-387.PubMed
66.
Chou FF, Sheen-Chen SM, Chen YS, Chen MC, Chen FC, Tai DI: Prognostic factor for pyogenic abscess of the liver. J Am Coll Surg. 1994, 179: 727-732.PubMed
67.
Maisels MJ: What's in a name? Physiologic and pathologic jaundice: The conundrum of defining normal bilirubin levels in the newborn. Pediatrics. 2006, 118: 805-807.PubMed
68.
Zanardo V, Golin R, Amato M, Trevisanuto D, Favaro F, Faggian D, Plebani M: Cytokines in human colostrum and neonatal jaundice. Pediatr Res. 2007, 62 (2): 191-194.PubMed
69.
Kadl A, Pontiller J, Exner M, Leitinger N: Single bolus injection of bilirubin improves the clinical outcome in a mouse model of endotoxemia. Shock. 2007, 28: 582-588.PubMed
70.
Carrico CJ, Meakins JL, Marshall JC, Fry D, Maier RV: Multiple-organ-failure syndrome. Arch Surg. 1986, 121: 196-208.PubMed
71.
Marshall JC, Christou NV, Meakins JL: The gastrointestinal tract. The "undrained abscess" of multiple organ failure. Ann Surg. 1993, 218: 111-119.PubMedCentralPubMed
72.
Gatt M, Reddy BS, MacFie J: Bacterial translocation in the critical ill. Evidence and methods of prevention. Aliment Pharmacol Ther. 2007, 25: 741-757.PubMed
73.
Cheadle WG, Turina M: Infection and organ failure in the surgical patient: a tribute to seminal contributions by Hiram C. Pok, Jr, MD. Am J Surg. 2005, 190: 173-177.PubMed
74.
Luyer MD, Buurman WA, Hadfoune M, Wolfs T, Van't Veer C, Jacobs JA, Dejong CH, Greve JWM: Exposure to bacterial DNA before hemorrhagic shock strongly aggravates systemic inflammation and gut barrier loss via an IFN-γ-dependent route. Ann Surg. 2007, 245: 795-802.PubMedCentralPubMed
75.
Ulloa L, Tracey KJ: The "cytokine profile": a code for sepsis. Trends Mol Med. 2005, 11: 56-63.PubMed
76.
Moseley RH: Sepsis and cholestasis. Clin Liver Dis. 1999, 3: 465-475.PubMed
77.
Marrero J, Martinez FJ, Hyzy R: Advances in critical care hepatology. Am J Respir Crit Care Med. 2003, 168: 1421-1426.PubMed
78.
Von Hundelshausen P, Weber C: Platelets as immune cells. Bridging inflammation and cardiovascular disease. Circ Res. 2007, 100: 27-40.PubMed
79.
Oberyszyn TM: Inflammation and wound healing. Front Biosci. 2007, 12: 2993-2999.PubMed
80.
Borregaard N, Sørensen OE, Theilgaard-Mönch K: Neutrophil granules: a library of innate immunity proteins. Trends Immunol. 2007, 28: 340-345.PubMed
81.
Heideman SM, Glibetic M: Comparison of the systemic and pulmonary inflammatory response to endotoxin of neutropenic and non-neutropenic rats. J Inflamm (Lond). 2007, 4: 7-
82.
Duffield JS: The inflammatory macrophage: a story of Jekyll and Hyde. Clin Sci. 2003, 104: 27-38.PubMed
83.
Serhan CN, Savill J: Resolution of inflammaton: the beginning programs the end. Nature Immunol. 1005, 6: 1191-1197.
84.
Meneghin A, Hogaboam GM: Infections disease, the innate immune response, and fibrosis. J Clin Invest. 2007, 117: 530-538.PubMedCentralPubMed
85.
Smith EM: Neuropeptides as signal molecules in common with leukocytes and the hypothalamic-pituitary-adrenal axis. Brain Behav Immun. 2007, 22: 3-14.PubMedCentralPubMed
86.
Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O'Neill LAJ, Peretti M, Rossi AG, Wallace JL: Resolution of inflammation: state of the art, definitions and terms. FASEB J. 2007, 21: 325-332.PubMedCentralPubMed
87.
Rajakariar R, Yaqoob MM, Gilroy DW: Cox-2 in inflammation and resolution. Mol Interv. 2006, 6: 199-207.PubMed
88.
Sitkovsky MV: T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response. Trends Immunol. 2009, 30: 102-108.PubMed
89.
Flavell SJ, Hou TZ, Lax S, Filer AD, Salmon M, Buckley CD: Fibroblasts as novel therapeutic targets in chronic inflammation. Br J Pharmacol. 2008, 153 (Suppl 1): S241-246.PubMedCentralPubMed
90.
Parsonage G, Filer AD, Haworth O, Nash GB, Rainger GE, Salmon M, Buckley CD: A stromal address code defined by fibroblasts. Trends Immunol. 2005, 26: 150-156.PubMedCentralPubMed
91.
Buckley CD, Pilling D, Lord JM, Akbar AN, Scheel-Toellner D, Salmon M: Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 2001, 22: 199-204.PubMed
92.
Changizi MA, Zhang Q, Shimojo S: Bare skin, blood and the evolution of primate colour vision. Biol Lett. 2006, 2: 217-221.PubMedCentralPubMed
93.
Beard DA, Wu F, Cabrera ME, Dash RK: Modeling of cellular metabolism and microcirculatory transport. Microcirculation. 2008, 15: 777-793.PubMed
94.
Madjdpour C, Heindl V, Spahn DR: Risks, benefits, alternatives and indications of allogenic blood transfusions. Minerva Anestesiol. 2006, 72: 283-298.PubMed
95.
Leow MKS: Configuration of the hemoglobin oxygen dissociation curve desmystified: a basic mathematical proof for medical and biological sciences undergraduates. Adv Physiol Educ. 2007, 31: 198-201.PubMed
96.
Ribatti D, Conconi MT, Nussdorfer GG: Nonclassic endogenous novel [corrected] regulators of angiogenesis. Pharmacol Rev. 2007, 59: 185-205.PubMed
97.
El Alwani M, Wu BX, Obeid LM, Hannun YA: Bioactive sphingolipids in the modulation of the inflammatory response. Pharmacol Ther. 2006, 112: 171-183.PubMed
98.
Ariel A, Serhan CN: Resolvins and protectins in the termination program of acute inflammation. Trends Immunol. 2007, 28: 176-183.PubMed
99.
Yacoubian S, Serhan CN: New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases. Nat Clin Pract Rheumatol. 2007, 3: 570-579.PubMed
100.
Clapp C, Aranda J, Gonzalez C, Jeziorski MC, Martinez de la Escalera G: Vasoinhibins: endogenous regulators of angiogenesis and vascular function. Trends Endocrinol Metabol. 2006, 17: 301-307.
101.
Gurtner GC, Werner S, Barrandon Y, Longaker MT: Wound repair and regeneration. Nature. 2008, 453: 314-321.PubMed
102.
Burns JL, Mancoll JS, Phillips LG: Impairments to wound healing. Clin Plastic Surg. 2003, 30: 47-56.
103.
Rahban SR, Garner WL: Fibroproliferative scars. Clin Plastic Surg. 2003, 30: 77-89.
104.
Arruda MA, Graça-Souza AV, Barja-Fidalgo C: Heme and innate immunity: a new insights for an old molecule. Mem Inst Oswaldo Cruz. 2005, 100: 799-803.PubMed
105.
Iredale JP: Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest. 2007, 117: 539-548.PubMedCentralPubMed
106.
Berghe Van Den G: Neuroendocrine axis in critical illness. Curr Opin Endocrinol Diabetes. 2001, 8: 47-54.
107.
Yasuhara S, Asai A, Sahani ND, Martín JA: Mitochondria, endoplasmic reticulum, and alternative pathways of cell death in critical illness. Crit Care Med. 2007, 35: S488-S495.PubMed
108.
Kiang NY, Siefert J, Govindjee , Blankenship RE: Spectral signatures of photosynthesis. I. Review of earth organisms. Astrobiology. 2007, 7: 222-251.PubMed
109.
Eckhardt U, Grimm B, Hörtensteiner S: Recent advances in chlorophyll biosynthesis and breakdown in higher plants. Plant Mol Biol. 2004, 56: 1-14.PubMed
110.
Tanaka A, Tanaka R: Chlorophyl metabolism. Curr Opin Plant Biol. 2006, 9: 248-255.PubMed
111.
Sasaki K, Watanabe M, Suda Y, Ishizuka A, Noparatnaraporn N: Applications of photosynthetic bacteria for medical fields. J Biosci Bioeng. 2005, 100: 481-488.PubMed
112.
Latunde-Dada GO, Simpson RJ, McKie AT: Recent advances in mammalian haem transport. Trends Biochem Sci. 2006, 31: 182-188.PubMed
113.
Reedy CJ, Elvekrog MM, Gibney BR: Development of a heme protein structure-electrochemical function database. Nucleic Acids Res. 2008, 36: D307-D313.PubMedCentralPubMed
114.
Tanaka R, Tanaka A: Tetrapyrrole biosynthesis in higher plants. Ann Rev Plant Biol. 2007, 58: 321-346.
115.
Hosler JP, Ferguson-Miller S, Mills DA: Energy transduction: Proton transfer through the respiratory complexes. Ann Rev Biochem. 2006, 75: 165-187.PubMedCentralPubMed
116.
Kiang NY, Segura A, Tinetti G, Govindjee , Blankenship RE, Cohen M, Sieffert J, Crisp D, Meadows VS: Spectral signatures of photosynthesis. II. Coevolution with other stars and the atmosphere on extrasolar worlds. Astrobiology. 2007, 7: 252-274.PubMed
117.
Ramon y Cajal S: Patogenia de la inflamación. Discurso de Doctorado. 2007, Edición facsímil. Universidad de Zaragoza y Gobierno de Aragón. INO Reproducciones S.A. Zaragoza, 1-109.
118.
Aragoneses J, Fraisl P, Baes M, Carmeliet P: Oxygen sensors at the crossroad of metabolism. Cell Metabolism. 2009, 9: 11-22.
119.
Jackson RM, Ann HS, Oparil S: Hypoxia-induced oxygen tolerante:maintenance of endotelial metabolic function. Exp Lung Res. 1988, 14: 887-896.PubMed
120.
Raymond J, Segre D: The effect of oxygen on biochemical networks and the evolution of complex life. Science. 2006, 311: 1764-1767.PubMed
121.
Acquisti C, Kleffe J, Collins S: Oxygen content of transmembrane proteins over macroevolutionary time scales. Nature. 2007, 445: 47-52.PubMed
122.
Porto BN, Alves LS, Fernandez PL, Dutra TP, Figueiredo RT, Graça-Souza AV, Bozza MT: Heme induces neutrophil migration and reactive oxygen species generation through signaling pathways characteristics of chemotactic receptors. J Biol Chem. 2007, 282: 24430-24436.PubMed
123.
Takahashi T, Shimizu H, Morimatsu H, Inoue K, Akagi R, Morita K, Sassa S: Heme oxygenase-1: a fundamental guardian against oxidative tissue injuries in acute inflammation. Mini Rev Med Chem. 2007, 7: 745-753.PubMed
124.
Siegbahn PEM, Blomberg MRA: Energy diagrams and mechanism for proton pumping in cytochrome C oxidase. Biochem Biophys Acta. 2007, 1767: 1143-1156.PubMed
125.
Battersby AR: Tetrapyrroles: the pigments of life. Nat Prod Rep. 2000, 17: 507-526.PubMed
126.
Avisar YJ, Beale SI: Biosynthesis of tetrapyrrole pigment precursors. (Pyridoxal requirement of the aminotransferase step in the formation of γ-amino-levulinate from glutamate in extracts of chlorella vulgaris). Plant Physiol. 1989, 89: 852-859.
127.
Ougham HJ, Morris P, Thomas H: The colors of autum leaves as symtoms of cellular recycling and defenses against environmental stresses. Curr Top Dev Biol. 2005, 66: 135-160.PubMed
128.
Ogawa M, Tani K, Ochiai A, Yamaguchi N, Nasu M: Multicolour digital image analysis system for identification of bacteria and concurrent assessment of their respiratory activity. J Appl Microbiol. 2005, 98: 1101-1106.PubMed
129.
Rochfort S: Metabolomics reviewed: a new "omics" platform technology for systems biology and implications for natural products research. J Nat Prod. 2005, 68: 1813-1820.PubMed
130.
Spratlin JL, Serkova NJ, Eckhardt SG: Clinical applications of metabolomics in oncology: a review. Clin Cancer Res. 2009, 15: 431-440.PubMedCentralPubMed
131.
Pipirov Z, Bottrill AR, Svistunenko DA, Efimov I, Basran J, Mistry SC, Cooper CE, Raven EL: The reactivity of heme in biological systems: Autocatalytic formation of both tyrosine-heme and truptophan-heme covalent links in a single protein architecture. Biochemistry. 2007, 46: 13269-13278.
132.
De Matteis F, Lord GA: Desferrioxamine dehydrogenates bilirubin in two stages, leading to a 1:1 red-coloured adduct characterization of the products by high-performance liquid cromatography/electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom. 2008, 22: 4055-4065.PubMed
133.
Aller MA, Arias JL, Arias JI, Sanchez-Patan F, Arias J: The inflammatory response recapitulates phylogeny through trophic mechanisms to the injured tissue. Med Hypotheses. 2007, 68: 202-209.PubMed
134.
Suo Z, Avci R, Schweitzer MH, Deliorman M: Porphyrin as an ideal biomarker in the search for extraterrestrial life. Astrobiology. 2007, 7: 605-615.PubMed
Metadata
Title
Surgical inflammation: a pathophysiological rainbow
Authors
Jose-Ignacio Arias
María-Angeles Aller
Jaime Arias
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2009
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-7-19

Other articles of this Issue 1/2009

Journal of Translational Medicine 1/2009 Go to the issue

Research

Let-7 microRNAs are developmentally regulated in circulating human erythroid cells

Research

Identification of HLA-A*2402-restricted HCMV immediate early-1 (IE-1) epitopes as targets for CD8+ HCMV-specific cytotoxic T lymphocytes

Research

Drugs targeting the mitochondrial pore act as citotoxic and cytostatic agents in temozolomide-resistant glioma cells

Research

KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells

Review

Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance

Research

Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits